Jeff Yass’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,268
Closed -$105K 13886
2022
Q4
$105K Buy
+10,268
New +$104K ﹤0.01% 10923

Other funds holding BIOSU

Jeff Yass's BIOSU Position: Q1 2023 in Review

Jeff Yass sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q1 2023, closing a stake of 10,268 shares — an estimated $105K sold.

Jeff Yass first reported a position in BIOSU in Q4 2022 and held it in 1 quarter. The position peaked at $105K in Q4 2022. 9 funds tracked by Wall St. Rank hold BIOSU as of Q1 2023.

  • Jeff Yass reported no remaining BioPlus Acquisition Corp. Unit position as of Q1 2023 after selling out during the quarter.
  • Jeff Yass sold 10,268 BioPlus Acquisition Corp. Unit shares in Q1 2023, an estimated $105K.
  • Jeff Yass first reported a position in BioPlus Acquisition Corp. Unit in Q4 2022 and held it in 1 quarter.
  • Jeff Yass's BioPlus Acquisition Corp. Unit position peaked at $105K in Q4 2022.
  • 9 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.